Trial Profile
A multicenter, randomized, double-blind, placebo-controlled, study evaluating PD-0299685 for treatment of vasomotor symptoms associated with menopause
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Apr 2022
Price :
$35
*
At a glance
- Drugs PD 0299685 (Primary)
- Indications Hot flashes
- Focus Therapeutic Use
- 12 Nov 2006 New trial record.